Open AccessEcchymosis: An Unexpected Side Effect of Montelukast
Author(s) -
G Eser,
Mustafa Berber,
Hülya Ercan Sarıçoban
Publication year - 2020
Publication title -
astım allerji immünoloji
Language(s) - English
Resource type - Journals
ISSN - 1308-9234
DOI - 10.21911/aai.570
Subject(s) - montelukast , ecchymosis , leukotriene receptor , antagonist , side effect (computer science) , medicine , leukotriene , drug , adverse effect , pharmacology , leukotriene d4 , asthma , dermatology , anesthesia , receptor , surgery , computer science , programming language
Montelukast is a leukotriene receptor antagonist that is used to treat allergy and asthma. It acts as a cysteinyl leukotriene receptor antagonist that blocks the action of leukotrienes and decreases inflammation. This agent is generally well tolerated in clinical practice. Although montelukast is generally considered as a safe drug, it can cause a few adverse drug reactions. In this case study, a rare side effect of montelukast that has been reported only twice before is presented. The importance of this case report is that the youngest patient who had ecchymosis due to the use of montelukast treatment is reported